Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer

BACKGROUND: [(18)F]fluorothymidine (FLT) has been proposed as a positron emission tomography (PET)-imaging biomarker of proliferation for breast cancer. The aim of this prospective study was to assess the feasibility of FLT-PET-CT as a technique for predicting the response to neoadjuvant chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Woolf, D K, Beresford, M, Li, S P, Dowsett, M, Sanghera, B, Wong, W L, Sonoda, L, Detre, S, Amin, V, Ah-See, M-L, Miles, D, Makris, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056049/
https://www.ncbi.nlm.nih.gov/pubmed/24832174
http://dx.doi.org/10.1038/bjc.2014.207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056049/
https://www.ncbi.nlm.nih.gov/pubmed/24832174
http://dx.doi.org/10.1038/bjc.2014.207

Ejemplares similares